ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

MPAC Mpac Group Plc

440.00
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Mpac Group Plc LSE:MPAC London Ordinary Share GB0005991111 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 440.00 435.00 445.00 440.00 440.00 440.00 1,996 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Special Industry Machy, Nec 114.2M 2.7M 0.1319 33.36 90.09M
Mpac Group Plc is listed in the Special Industry Machy sector of the London Stock Exchange with ticker MPAC. The last closing price for Mpac was 440p. Over the last year, Mpac shares have traded in a share price range of 185.00p to 472.50p.

Mpac currently has 20,474,424 shares in issue. The market capitalisation of Mpac is £90.09 million. Mpac has a price to earnings ratio (PE ratio) of 33.36.

Mpac Share Discussion Threads

Showing 201 to 224 of 2075 messages
Chat Pages: Latest  11  10  9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
20/7/2019
14:56
Evil Knievel has been bullish on this again and said that when the property development issue is resolved he can see it easily going to 250P.

I think they have for sometime being trying to sell off a site for development, possibly in High Wycombe but had been refused planning permission. I think over a year ago they were sounding positive about getting planning permission with a new proposal but I have not heard much since unless I missed something.

Does anyone know what is happening in that regard?

richjp
19/7/2019
15:09
Equity Development note very bullish too:

"the business is literally flying with FY19 results anticipated to be “significantly above market expectations"

"we suspect that a big chunk of this incremental revenue is coming from the ‘economically resilient’ healthcare sector. Here there are multi-year upselling opportunities"

"Consequently, due to the strong H1 and encouraging outlook, we have raised our valuation from 245p to 260p/share – underpinned by excellent visibility for H2’19, based on YTD revenues, orderbook flow-through and normal repeat service business."

cf456
19/7/2019
14:57
"I feel that shares have strong potential to surpass my previous target price of 225p as more investors cotton on to the strong earnings upgrade momentum that is unfolding. In fact, I have upgraded my target price to 250p. I am not the only one as Panmure have raised their target this morning from 259p to 300p and Equity Development have upgraded their target from 245p to 260p. Strong buy."
cf456
16/7/2019
21:58
As trade grew then more money tied up in debtors?
castleford tiger
16/7/2019
20:00
Thanks Gary
alan@bj
16/7/2019
19:12
Alan,

Net cash per the accounts at 31st Dec was £27m and they have spent £15m on the acquisition so leaves £12m. In reality they probably increased cash between Jan-Apr prior to the acquisition.

Gary

gary1966
16/7/2019
17:02
Gary

I took the figure from the note.

See above

cheers tiger

castleford tiger
16/7/2019
16:48
Where did you get the figure of £12m from Gary? Not saying you're wrong, just querying it.

Simon Thompson's article says:- "After taking into account the £15m cash consideration paid for Lambert in May, analyst Paul Hill at Equity Development believes that Mpac will end this year with net cash of £9.5m, a sum worth 47p a share based on 20.17m shares in issue.

This means that not only are Mpac’s shares trading on a miserly current year price/earnings (PE) ratio of 8, and on a cash-adjusted basis the PE ratio is only 6. That’s an incredibly low earnings multiple to pay for a company that is on course to lift EPS by 42 per cent from 23.6p in 2019 to 33.7p in 2021 based on Mpac delivering £7.7m of pre-tax profit on revenues of £101m in 2021, according to analyst Sanjay Jha at Panmure. In fact, Mpac’s forward PE ratio for 2019 is half the UK engineering sector average."

alan@bj
16/7/2019
16:22
CT,

They had £12m cash after the acquisition based on the year end accounts and so why do you think they will be cash outflow this year to bring down to £9m? Trading significantly ahead, cost synergies, surely cash will grow this year.

Anyway nice to see a great rise after a day out.

GLA

gary1966
16/7/2019
13:42
Strong buy from ST, he's moved target to 250, Edison 260, Panmure 300.



250 still sounds cheap to me with their cash and pipeline and relative safety from brexit related fx worries most earnings coming from the US.

paleje
16/7/2019
11:16
very close to 200p now
tiger

castleford tiger
16/7/2019
10:25
When does he publish?
momentum1
16/7/2019
10:20
Simon Thompson - Investors Chronicle
hamsterdam
16/7/2019
10:05
Who is ST?
momentum1
16/7/2019
09:38
ST has been a supporter of these so expect a column from him over the coming days.
paleje
16/7/2019
08:24
cash is forecast to be about 9m

agree 300p is fair value
tiger

castleford tiger
16/7/2019
08:03
ED are behind the curve hugely then. EPS will be 20p plus this year with end of year cash around £14m I suspect. These are worth well north of £3 on any metric. Market will cotton on, we just have to be patient.
gary1966
16/7/2019
07:52
Agreed - looks a terrific H1 with this trend set to continue on the back of a strong order book.

Equity Development research now out, with upgrades for both forecasts and fair value/share at 260p (up from 245p).

Full note here:

edmonda
16/7/2019
07:08
Can’t ask for a more bullish TU than that, well done the team at MPAC. Looking forward to seeing the numbers in 7 weeks.
gary1966
16/7/2019
07:05
Significantly ahead - that's nice.
broadwood
16/7/2019
07:01
Welcome statement
capercaillie
03/7/2019
09:44
Hi Castleford Tiger,


Yes, we still have to make the annual payments.


If the actuarial calculation was dated as at June 2019, rather than as at June 2018, the déficit on a technical provision basis would be significantly smaller.



We are in surplus on the Ias 19 basis for calculating the déficit.

cjohn
21/6/2019
11:02
Dilip40,

Underlying Profit/EPS of £1.4m and 4.5p. Mkt cap just under £33m and cash at last year end of £27m. Chunk of that cash spent on Lambert Automation acquisition which is immediately materially earnings enhancing. Order book for both businesses at record levels. Trading this year off to good start. All in all very cheap given that even after the acquisition, cash probably represents half the market cap.

gary1966
21/6/2019
10:41
co made loss 2018 -30p eps any forecasts for 2019 2020
dilip40
Chat Pages: Latest  11  10  9  8  7  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock